These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

829 related items for PubMed ID: 9382750

  • 1. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.
    Johansen HK, Cryz SJ, Hougen HP, Moser C, Høiby N.
    Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750
    [Abstract] [Full Text] [Related]

  • 2. Chronic Pseudomonas aeruginosa lung infection is more severe in Th2 responding BALB/c mice compared to Th1 responding C3H/HeN mice.
    Moser C, Johansen HK, Song Z, Hougen HP, Rygaard J, Høiby N.
    APMIS; 1997 Nov; 105(11):838-42. PubMed ID: 9393554
    [Abstract] [Full Text] [Related]

  • 3. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia in rats.
    Johansen HK, Hougen HP, Cryz SJ, Rygaard J, Høiby N.
    Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1337-46. PubMed ID: 7551392
    [Abstract] [Full Text] [Related]

  • 4. Experimental chronic Pseudomonas aeruginosa lung infection in rats. Non-specific stimulation with LPS reduces lethality as efficiently as specific immunization.
    Lange KH, Hougen HP, Høiby N, Fomsgaard A, Rygaard J, Johansen HK.
    APMIS; 1995 May; 103(5):367-74. PubMed ID: 7654361
    [Abstract] [Full Text] [Related]

  • 5. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O.
    APMIS Suppl; 2003 May; (116):1-47. PubMed ID: 14692154
    [Abstract] [Full Text] [Related]

  • 6. Serum concentrations of GM-CSF and G-CSF correlate with the Th1/Th2 cytokine response in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection.
    Moser C, Jensen PØ, Pressler T, Frederiksen B, Lanng S, Kharazmi A, Koch C, Høiby N.
    APMIS; 2005 Jun; 113(6):400-9. PubMed ID: 15996157
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cytokine modulating effect of ginseng treatment in a mouse model of Pseudomonas aeruginosa lung infection.
    Song Z, Moser C, Wu H, Faber V, Kharazmi A, Høiby N.
    J Cyst Fibros; 2003 Sep; 2(3):112-9. PubMed ID: 15463859
    [Abstract] [Full Text] [Related]

  • 9. Potential of preventing Pseudomonas aeruginosa lung infections in cystic fibrosis patients: experimental studies in animals.
    Johansen HK.
    APMIS Suppl; 1996 Sep; 63():5-42. PubMed ID: 8944052
    [Abstract] [Full Text] [Related]

  • 10. Acute Pseudomonas challenge in cystic fibrosis mice causes prolonged nuclear factor-kappa B activation, cytokine secretion, and persistent lung inflammation.
    Saadane A, Soltys J, Berger M.
    J Allergy Clin Immunol; 2006 May; 117(5):1163-9. PubMed ID: 16675347
    [Abstract] [Full Text] [Related]

  • 11. Effects of Chinese medicinal herbs on a rat model of chronic Pseudomonas aeruginosa lung infection.
    Song Z, Johansen HK, Moser C, Høiby N.
    APMIS; 1996 May; 104(5):350-4. PubMed ID: 8703440
    [Abstract] [Full Text] [Related]

  • 12. Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Pier GB.
    Behring Inst Mitt; 1997 Feb; (98):350-60. PubMed ID: 9382760
    [Abstract] [Full Text] [Related]

  • 13. Early immune response in susceptible and resistant mice strains with chronic Pseudomonas aeruginosa lung infection determines the type of T-helper cell response.
    Moser C, Hougen HP, Song Z, Rygaard J, Kharazmi A, Høiby N.
    APMIS; 1999 Dec; 107(12):1093-100. PubMed ID: 10660139
    [Abstract] [Full Text] [Related]

  • 14. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis.
    Pedersen SS.
    APMIS Suppl; 1992 Dec; 28():1-79. PubMed ID: 1449848
    [Abstract] [Full Text] [Related]

  • 15. Augmented effect of early antibiotic treatment in mice with experimental lung infections due to sequentially adapted mucoid strains of Pseudomonas aeruginosa.
    van Gennip M, Moser C, Christensen LD, Bjarnsholt T, Calum H, Jensen PØ, Christophersen L, Hougen HP, Ciofu O, Molin S, Givskov M, Høiby N.
    J Antimicrob Chemother; 2009 Dec; 64(6):1241-50. PubMed ID: 19815632
    [Abstract] [Full Text] [Related]

  • 16. Pulmonary T(H)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis.
    Hartl D, Griese M, Kappler M, Zissel G, Reinhardt D, Rebhan C, Schendel DJ, Krauss-Etschmann S.
    J Allergy Clin Immunol; 2006 Jan; 117(1):204-11. PubMed ID: 16387607
    [Abstract] [Full Text] [Related]

  • 17. Interferon-gamma (IFN-gamma) treatment decreases the inflammatory response in chronic Pseudomonas aeruginosa pneumonia in rats.
    Johansen HK, Hougen HP, Rygaard J, Høiby N.
    Clin Exp Immunol; 1996 Feb; 103(2):212-8. PubMed ID: 8565302
    [Abstract] [Full Text] [Related]

  • 18. Induction of experimental chronic Pseudomonas aeruginosa lung infection with P. aeruginosa entrapped in alginate microspheres.
    Pedersen SS, Shand GH, Hansen BL, Hansen GN.
    APMIS; 1990 Mar; 98(3):203-11. PubMed ID: 2107827
    [Abstract] [Full Text] [Related]

  • 19. Increased severity of Pseudomonas aeruginosa corneal infection in strains of mice designated as Th1 versus Th2 responsive.
    Hazlett LD, McClellan S, Kwon B, Barrett R.
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):805-10. PubMed ID: 10711697
    [Abstract] [Full Text] [Related]

  • 20. Intratracheal immunization with pili protein protects against mortality associated with Pseudomonas aeruginosa pneumonia in mice.
    Ohama M, Hiramatsu K, Miyajima Y, Kishi K, Nasu M, Kadota J.
    FEMS Immunol Med Microbiol; 2006 Jun; 47(1):107-15. PubMed ID: 16706793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.